Melissa PGeo - New Found Vice Exploration
NFG Stock | CAD 2.53 0.06 2.32% |
Executive
Melissa PGeo is Vice Exploration of New Found Gold
Address | 1600 - 595 Burrard Street, Vancouver, BC, Canada, V7X 1L4 |
Phone | 845-535-1486 |
Web | https://newfoundgold.ca |
New Found Management Efficiency
The company has return on total asset (ROA) of (0.6586) % which means that it has lost $0.6586 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0968) %, meaning that it generated substantial loss on money invested by shareholders. New Found's management efficiency ratios could be used to measure how well New Found manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.99 in 2024. Return On Capital Employed is likely to drop to -1.66 in 2024. At this time, New Found's Net Tangible Assets are fairly stable compared to the past year. Total Assets is likely to climb to about 93.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 11.8 M in 2024.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Richard Roos | NorthWest Healthcare Properties | 58 | |
Brian CPA | UnitedHealth Group CDR | 49 | |
Avjitpal Kamboj | Converge Technology Solutions | N/A | |
John Teltsch | Converge Technology Solutions | N/A | |
Rupert Bondy | UnitedHealth Group CDR | 62 | |
Greg Rhoades | Converge Technology Solutions | N/A | |
William Zehnder | Quipt Home Medical | 49 | |
Terry Schmitt | NorthWest Healthcare Properties | N/A | |
Karie Timion | Converge Technology Solutions | N/A | |
Graham Cromb | Andlauer Healthcare Gr | N/A | |
Erin McSweeney | UnitedHealth Group CDR | 59 | |
Sandeep Dadlani | UnitedHealth Group CDR | 49 | |
Tracey Whittall | NorthWest Healthcare Properties | N/A | |
Brian Thompson | UnitedHealth Group CDR | 49 | |
Dave Casimiro | NorthWest Healthcare Properties | N/A | |
Michael Goodman | WELL Health Technologies | N/A | |
Patrick Gamble | Quipt Home Medical | N/A | |
Thomas Roos | UnitedHealth Group CDR | 51 | |
Robert LLB | Quipt Home Medical | 50 | |
Chris Ericksen | WELL Health Technologies | N/A | |
Sean Colicchio | Converge Technology Solutions | N/A |
Management Performance
Return On Equity | -1.1 | ||||
Return On Asset | -0.66 |
New Found Gold Leadership Team
Elected by the shareholders, the New Found's board of directors comprises two types of representatives: New Found inside directors who are chosen from within the company, and outside directors, selected externally and held independent of New. The board's role is to monitor New Found's management team and ensure that shareholders' interests are well served. New Found's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, New Found's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ronald Hampton, Chief Officer | ||
Kenneth Bsc, Geologist | ||
BSc BSc, President Founder | ||
Janet Francis, Corporate Secretary | ||
Collin Kettell, Executive Founder | ||
Melissa PGeo, Vice Exploration |
New Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is New Found a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.1 | ||||
Return On Asset | -0.66 | ||||
Current Valuation | 462.74 M | ||||
Shares Outstanding | 198.91 M | ||||
Shares Owned By Insiders | 44.04 % | ||||
Shares Owned By Institutions | 4.82 % | ||||
Number Of Shares Shorted | 1.22 M | ||||
Price To Book | 6.38 X | ||||
EBITDA | (79.44 M) | ||||
Net Income | (79.89 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for New Stock Analysis
When running New Found's price analysis, check to measure New Found's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Found is operating at the current time. Most of New Found's value examination focuses on studying past and present price action to predict the probability of New Found's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Found's price. Additionally, you may evaluate how the addition of New Found to your portfolios can decrease your overall portfolio volatility.